PPARα agonist fenofibrate relieves acquired resistance to gefitinib in non-small cell lung cancer by promoting apoptosis via PPARα/AMPK/AKT/FoxO1 pathway
Meisa Wang, Qiushuang Han, Zhirong Jia, Chuan-sheng Chen, Chen Qiao, Qianqian Liu, Yameng Zhang, Kai-wei Wang, Jie Wang, Kang Xiao, Xuansheng Ding
Topics & Concepts
GefitinibFenofibrateABCA1AMPKProtein kinase BApoptosisPharmacologyCell growthCancer researchPI3K/AKT/mTOR pathwayRosuvastatinEndocrinologyMedicineChemistryInternal medicineEpidermal growth factor receptorKinaseCancerProtein kinase ABiochemistryTransporterGeneCancer, Lipids, and MetabolismPeroxisome Proliferator-Activated ReceptorsDrug Transport and Resistance Mechanisms